EU SCIENTISTS CREATE NEW MEDICINAL USE FOR TOBACCO PLANTS
May 1st, 2009
BY KEITH NUTHALL
A EURO 12 million European Union (EU) research project has developed genetically modified tobacco plants able to produce a pharmacologically active substance treating autoimmune and inflammatory diseases. Pharma-Planta project scientists have created interleukin-10 (IL-10) from these tobacco plants at sufficiently high levels for effective extraction and purification. IL-10 is a protein that regulates the immune system. The project was coordinated by Italy's University of Verona along with scientists from Germany, Austria and the University of ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.